Tyrosine Protein Kinase SYK Market Size, Share, Analysis, Industry Report and Forecast 2021-2027
The global tyrosine protein kinase SYK market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Tyrosine protein kinase SYK is also known as spleen tyrosine kinase (SYK). It is a non-receptor cytoplasmic enzyme and is primarily expressed in cells of hematopoietic lineage. It contains two adjacent SH2 domains that bind to immunoreceptor tyrosine-based activation motifs (ITAMs) to activate the enzyme. The major factor driving the growth of the market is the rising prevalence of arthritis across the globe.
According to Arthritis Org, in 2020, over 54 million adults
had doctor-diagnosed arthritis with more than 1 in 4 US adults. Additionally,
almost 300,000 children had arthritis in 2020. Furthermore, this disease
affects more adults younger than age 65 with more than 1 in 3 people (both men
and women), aged 18 to 64, having symptoms consistent with arthritis. Hence,
the rising prevalence of arthritis is driving the demand for tyrosine protein
kinase SYK for treatment which in turn is driving the growth of the market.
Moreover, Fostamatinib was the first oral SYK inhibitor used for the treatment
of rheumatoid arthritis and lymphoid malignancies.
To Request a Sample of our Report on Tyrosine Protein
Kinase SYK Market: https://www.omrglobal.com/request-sample/tyrosine-protein-kinase-syk-market
Some major players in the market include Celgene Corp.,
Gilead Sciences Inc., among others. The market players are contributing
significantly to the growth of the market by the adoption of various strategies
including mergers & acquisitions, geographical expansion, partnerships and
collaborations, and new product launches, to stay competitive in the market.
For instance, in July 2021, Kronos Bio announced that the FDA cleared its IND
for next-generation spleen tyrosine kinase (SYK) inhibitor lanraplenib (LANRA)
for relapsed/refractory and newly diagnosed acute myeloid leukemia (AML).
Market Coverage
• The
market number available for – 2020-2027
• Base
year- 2020
• Forecast
period- 2021-2027
Segment Covered-
•
By Type
•
By Application
Regions Covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
Competitive Landscape-
Celgene Corp., Clevexel Pharma SAS, Gilead Sciences Inc., GlaxoSmithKline Plc,
among others.
(Get 15% Discount on Buying this Report)
A
full Report of Tyrosine Protein Kinase SYK Market is Available @ https://www.omrglobal.com/industry-reports/tyrosine-protein-kinase-syk-market
Global Tyrosine Protein Kinase SYK Market Report Segment
By Type
•
HMPL-523
•
C-13
•
CVXL-0074
•
ASN-002
•
FF-10102
•
Others
By Application
• Anaphylactic
Shock
• Arthritis
• Fallopian
Tube Cancer
• Lupus
Naphritis
• Other
Global Tyrosine Protein Kinase SYK Market Report by
Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment